Translate Bio, Inc.
CIK 0001693415
Revenue (TTM)
$190.01M
−22.7% YoY
Q2 Aug 2021
Net Income (TTM)
$24.72M
−218.5% YoY
Q2 Aug 2021
EPS Diluted (TTM)
$0.20
−195.7% YoY
Q2 Aug 2021
Gross Margin
—
Q2 Aug 2021
Operating Margin
12.0%
Q2 Aug 2021
Net Margin
13.0%
Q2 Aug 2021
Free Cash Flow (TTM)
−$77.08M
Q2 Aug 2021
Cash
$249.47M
Q2 Aug 2021
Total Debt
—
Q2 Aug 2021
Shares Outstanding
75.59M sh
Q2 Aug 2021